Skip to main content
. 2020 May 21;11(7):1835–1839. doi: 10.1111/1759-7714.13461

Figure 3.

Figure 3

Survival curves of two groups based on treatment of patients with or without antivascular targeted drugs. There was a benefit tendency for the group receiving targeted drugs after chemotherapy, but the overall survival between these two groups did not have a significant difference (Inline graphic) No, (Inline graphic) Yes.